About Iovance Biotherapeutics
Iovance Biotherapeutics (IOVA) is a late-stage biotechnology company developing novel cancer immunotherapies based on its tumor-infiltrating lymphocyte (TIL) technology. Iovance announced promising updates from ongoing clinical trials in advanced cervical cancer and advanced melanoma.
The data will be presented at the 55th Annual . . .
This content is for paid subscribers.
Today’s Highlights May 16, 2019